在卵巢生殖细胞瘤之后,多种恶性瘤的快速连续发展:诊断,治疗和监测挑战
Shahrzad Sheikhhasani1, Fereshteh Ameli2, Mina Sadat Mosavat1
1Vali-e-Asr Reproductive Health Research Center, Family Health Research Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
International journal of surgery case reports
|August 8, 2025
概括
患有卵巢生殖细胞瘤的年轻女性面临二次癌症风险. 这一案例凸显了改善长期监测和为幸存者提供个性化治疗的必要性.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 生殖医学 生殖医学
背景情况:
- 卵巢生殖细胞瘤 (OGCTs) 是一种罕见的癌症,影响年轻女性.
- 基于的化疗改善了OGCT的预后,但存在二次恶性瘤的风险.
- 由于这些风险,幸存者需要持续的临床管理.
更多相关视频
08:17Murine Experimental Model of Original Tumor Development and Peritoneal Metastasis via Orthotopic Inoculation with Ovarian Carcinoma Cells
Published on: December 9, 2016
10.7K
14:25Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time
Published on: May 20, 2014
17.5K
相关概念视频
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
